Your browser is no longer supported. Please, upgrade your browser.
Settings
CRL Charles River Laboratories International, Inc. daily Stock Chart
CRL [NYSE]
Charles River Laboratories International, Inc.
Index- P/E27.32 EPS (ttm)3.22 Insider Own1.60% Shs Outstand47.32M Perf Week-1.15%
Market Cap4.16B Forward P/E15.61 EPS next Y5.63 Insider Trans-5.21% Shs Float46.48M Perf Month10.72%
Income154.50M PEG2.40 EPS next Q1.14 Inst Own99.20% Short Float4.66% Perf Quarter19.63%
Sales1.68B P/S2.47 EPS this Y2.10% Inst Trans-1.02% Short Ratio5.16 Perf Half Y5.19%
Book/sh17.73 P/B4.96 EPS next Y11.35% ROA6.00% Target Price94.33 Perf Year21.23%
Cash/sh2.57 P/C34.27 EPS next 5Y11.40% ROE18.70% 52W Range67.20 - 89.59 Perf YTD15.41%
Dividend- P/FCF17.12 EPS past 5Y7.50% ROI8.20% 52W High-1.85% Beta1.02
Dividend %- Quick Ratio1.30 Sales past 5Y8.00% Gross Margin38.50% 52W Low30.85% ATR1.65
Employees11000 Current Ratio1.50 Sales Q/Q31.90% Oper. Margin14.10% RSI (14)73.07 Volatility1.44% 1.86%
OptionableYes Debt/Eq1.48 EPS Q/Q34.90% Profit Margin9.20% Rel Volume0.68 Prev Close88.40
ShortableYes LT Debt/Eq1.44 EarningsFeb 14 BMO Payout0.00% Avg Volume420.02K Price87.93
Recom2.30 SMA205.82% SMA5010.28% SMA2008.59% Volume285,900 Change-0.53%
Dec-16-16Upgrade Goldman Sell → Neutral
Nov-30-16Upgrade Barclays Underweight → Equal Weight $65 → $77
Sep-06-16Downgrade UBS Neutral → Sell $83 → $78
Jun-21-16Initiated Credit Suisse Neutral $84
May-20-16Reiterated Barclays Underweight $60 → $65
Apr-26-16Initiated Gabelli & Co Buy $96
Jan-07-16Upgrade Wells Fargo Market Perform → Outperform
Oct-12-15Upgrade Wells Fargo Underperform → Market Perform
Jul-31-15Reiterated Deutsche Bank Hold $76 → $79
Jul-10-15Upgrade BofA/Merrill Neutral → Buy $76 → $83
Jul-10-15Downgrade Barclays Equal Weight → Underweight $60
May-04-15Upgrade Sun Trust Rbsn Humphrey Neutral → Buy $88
Apr-24-15Reiterated Barclays Equal Weight $55 → $60
Feb-12-15Reiterated Deutsche Bank Hold $63 → $77
Feb-13-14Reiterated Barclays Equal Weight $41 → $55
Nov-21-13Initiated Deutsche Bank Hold $55
Sep-17-13Initiated UBS Neutral $49
Jun-03-13Reiterated Barclays Equal Weight $38 → $41
May-02-13Reiterated ISI Group Neutral $45.50 → $44.50
Feb-14-13Reiterated ISI Group Neutral $40.50 → $43
Feb-18-17 01:04PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Financials
Feb-16-17 12:28PM  Charles River Laboratories International, Inc. :CRL-US: Earnings Analysis: 2016 By the Numbers : February 16, 2017
Feb-15-17 10:23AM  Charles River Laboratories International, Inc. :CRL-US: Earnings Analysis: Q4, 2016 By the Numbers : February 15, 2017
Feb-14-17 05:03PM  Edited Transcript of CRL earnings conference call or presentation 14-Feb-17 1:00pm GMT +7.86%
08:00AM  Charles River Laboratories International Inc Earnings Call scheduled for 8:00 am ET today
07:07AM  Q4 2016 Charles River Laboratories International Inc Earnings Release - Before Market Open
07:01AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan
06:48AM  Charles River tops Street 4Q forecasts
06:30AM  Charles River Laboratories Announces Fourth-Quarter and Full-Year 2016 Results from Continuing Operations and Provides 2017 Guidance Business Wire
Feb-13-17 08:57AM  Healthcare Stock Q4 Earnings Slated for Feb 14: ESRX, CRL, Q
Feb-09-17 08:30AM  Charles River Laboratories Changes Time of Fourth-Quarter 2016 Earnings and 2017 Guidance Conference Call Business Wire
Jan-30-17 08:00AM  Charles River Laboratories Announces Progress Update for Collaboration with Moderna Therapeutics Business Wire
Jan-20-17 04:56PM  John Rogers Comments on Charles River Laboratories Intl
03:28PM  John Rogers' Ariel Fund 4th Quarter Commentary
Jan-19-17 04:30PM  Charles River Laboratories Schedules Fourth-Quarter 2016 Earnings and 2017 Guidance Release and Conference Call Business Wire
Jan-10-17 07:22AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition
Jan-09-17 08:30AM  Charles River Laboratories to Present at J.P. Morgan Healthcare Conference Business Wire
Dec-26-16 07:07AM  Charles River Laboratories International, Inc. breached its 50 day moving average in a Bullish Manner : CRL-US : December 26, 2016
Dec-16-16 10:25AM  Charles River Laboratories International, Inc. Value Analysis (NYSE:CRL) : December 16, 2016
08:14AM  Analysts' Actions -- GE, Nordstrom, Coca-Cola, Eli Lilly and More
07:54AM  Charles River upgraded by Goldman
Dec-15-16 07:04AM  Charles River Laboratories International, Inc. breached its 50 day moving average in a Bullish Manner : CRL-US : December 15, 2016
Dec-12-16 02:12PM  ETFs with exposure to Charles River Laboratories International, Inc. : December 12, 2016
Dec-01-16 08:00AM  Charles River Laboratories Demonstrates Expertise in CRISPR/Cas9 Genome Engineering Technology Business Wire
Nov-26-16 07:44PM  Is Charles River Laboratories Intl. Inc (CRL) A Good Stock for Your Portfolio? at Insider Monkey
Nov-10-16 08:00AM  Charles River Laboratories Presents Robust Program at Neuroscience 2016 Business Wire
Nov-07-16 12:17PM  ETFs with exposure to Charles River Laboratories International, Inc. : November 7, 2016
Nov-04-16 11:11AM  Charles River Laboratories International, Inc. :CRL-US: Earnings Analysis: Q3, 2016 By the Numbers : November 4, 2016
Nov-02-16 02:55PM  Edited Transcript of CRL earnings conference call or presentation 2-Nov-16 12:30pm GMT -5.35%
02:46PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers
08:30AM  Charles River Laboratories International Inc Earnings Call scheduled for 8:30 am ET today
07:40AM  Charles River beats 3Q profit forecasts
07:07AM  Q3 2016 Charles River Laboratories International Inc Earnings Release - Before Market Open
07:00AM  Charles River Laboratories Announces Third-Quarter 2016 Results from Continuing Operations Business Wire
Oct-21-16 08:04AM  Charles River Laboratories International, Inc. breached its 50 day moving average in a Bullish Manner : CRL-US : October 21, 2016
Oct-19-16 11:34AM  ETFs with exposure to Charles River Laboratories International, Inc. : October 19, 2016
Oct-11-16 08:00AM  Charles River Announces Extension of Integrated Discovery Program with Genentech Business Wire
Oct-10-16 08:17AM  Charles River Laboratories International, Inc. breached its 50 day moving average in a Bearish Manner : CRL-US : October 10, 2016
Oct-06-16 08:30AM  Charles River Laboratories Schedules Third-Quarter 2016 Earnings Release and Conference Call Business Wire
Sep-30-16 09:45AM  ETFs with exposure to Charles River Laboratories International, Inc. : September 30, 2016
Sep-29-16 10:08AM  Charles River Laboratories International, Inc. Value Analysis (NYSE:CRL) : September 29, 2016
Sep-28-16 04:30PM  Charles River Laboratories Acquires Agilux Laboratories, Inc. Business Wire
08:02AM  Charles River Laboratories International, Inc. breached its 50 day moving average in a Bullish Manner : CRL-US : September 28, 2016
Sep-22-16 08:00AM  Charles River Laboratories and The Tri-Insitutional Therapeutics Discovery Institute Announce Strategic Partnership Business Wire
Sep-13-16 06:00AM  Jim Cramer's Top Takeaways: Impinj, Charles River Labs
Sep-12-16 07:06PM  Cramer Remix: The stock with the most momentum in the S&P or Nasdaq at CNBC
Sep-06-16 08:30AM  Charles River Laboratories to Present at September Investor Conferences Business Wire
Aug-31-16 08:05AM  Charles River Laboratories International, Inc. breached its 50 day moving average in a Bullish Manner : CRL-US : August 31, 2016
Aug-18-16 05:56PM  Moody's Upgrades Two, Affirms Three and Downgrades One Class of MLCFC 2006-2 at Moody's
Aug-11-16 10:44AM  Will This Clinical Researcher Become Next Breakout Medical Stock?
Aug-10-16 03:32PM  ETFs with exposure to Charles River Laboratories International, Inc. : August 10, 2016
Aug-09-16 08:16AM  Charles River Laboratories International, Inc. breached its 50 day moving average in a Bearish Manner : CRL-US : August 9, 2016
Aug-08-16 04:30PM  Charles River Laboratories Announces Partnership with the Milner Therapeutics Institute and Consortium Business Wire
12:07PM  Charles River Laboratories International, Inc. :CRL-US: Earnings Analysis: Q2, 2016 By the Numbers : August 8, 2016
Aug-03-16 04:44PM  Edited Transcript of CRL earnings conference call or presentation 3-Aug-16 12:30pm GMT
08:30AM  Charles River Laboratories International Inc Earnings Call scheduled for 8:30 am ET today
07:31AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan
07:22AM  Charles River beats Street 2Q forecasts
07:07AM  Q2 2016 Charles River Laboratories International Inc Earnings Release - Before Market Open
07:00AM  Charles River Laboratories Announces Second-Quarter 2016 Results from Continuing Operations Business Wire
Aug-02-16 10:36AM  Healthcare Q2 Earnings Lineup for Aug 3: HUM, CRL & More
Jul-11-16 04:30PM  Charles River Laboratories Schedules Second-Quarter 2016 Earnings Release and Conference Call Business Wire
Jul-04-16 08:24AM  Charles River Laboratories International, Inc. breached its 50 day moving average in a Bullish Manner : CRL-US : July 4, 2016
Jun-30-16 03:40PM  ETFs with exposure to Charles River Laboratories International, Inc. : June 30, 2016
06:50AM  Charles River CEO: 'Companies that dont grow, die' at bizjournals.com
Jun-29-16 10:34AM  5 Stocks to Buy on Stronger GDP Data
Jun-27-16 04:30PM  Charles River Laboratories Acquires Blue Stream Laboratories Business Wire -5.48%
Jun-21-16 02:22PM  Charles River Labs (CRL) Stock Falls, Credit Suisse Initiates Coverage
11:23AM  Charles River Laboratories International, Inc. Value Analysis (NYSE:CRL) : June 21, 2016
Jun-20-16 08:35AM  Charles River Laboratories International, Inc. breached its 50 day moving average in a Bearish Manner : CRL-US : June 20, 2016
Jun-15-16 04:21PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets
Jun-06-16 08:30AM  Charles River Laboratories to Present at Jefferies and William Blair Conferences Business Wire
08:00AM  Moderna Therapeutics and Charles River Laboratories Announce Strategic Collaboration to Scale Modernas Nonclinical Development Efforts for Novel mRNA Therapeutics Business Wire
May-16-16 09:26AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K/A, Change in Directors or Principal Officers
06:11AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in
May-12-16 03:29PM  ETFs with exposure to Charles River Laboratories International, Inc. : May 12, 2016
May-10-16 10:50AM  Charles River Laboratories International, Inc. :CRL-US: Earnings Analysis: Q1, 2016 By the Numbers
May-04-16 05:31PM  Edited Transcript of CRL earnings conference call or presentation 4-May-16 12:30pm GMT
08:30AM  Charles River Laboratories International Inc Earnings Call scheduled for 8:30 am ET today
07:20AM  Charles River beats Street 1Q forecasts
07:16AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan
07:07AM  Q1 2016 Charles River Laboratories International Inc Earnings Release - Before Market Open CCBN
07:00AM  Charles River Laboratories Announces First-Quarter 2016 Results from Continuing Operations Business Wire
Apr-27-16 09:30AM  The Zacks Analyst Blog Highlights: Emergent BioSolutions, Molina Healthcare, PAREXEL International, Air Methods and Charles River Laboratories International Zacks
Apr-26-16 02:32PM  Street Talk: CAT, TCS, NEM & more CNBC
11:42AM  5 Stocks to Invest on Healthcare Rebound Zacks
Apr-19-16 11:05AM  Biotech startup space Mass Innovation Labs to double Cambridge space at bizjournals.com
Apr-13-16 04:30PM  Charles River Laboratories and BioMotiv Enter into Strategic Partnership Business Wire
Apr-07-16 04:30PM  Charles River Laboratories Schedules First-Quarter 2016 Earnings Release and Conference Call Business Wire
Apr-05-16 09:18AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets,
Apr-04-16 08:55AM  Charles River Laboratories Completes the Acquisition of WIL Research Business Wire
Mar-14-16 08:24AM  Charles River Laboratories International, Inc. breached its 50 day moving average in a Bullish Manner : CRL-US : March 14, 2016
Mar-10-16 08:29AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers
Mar-07-16 08:30AM  Charles River Laboratories to Present at Raymond James Conference Business Wire
Mar-03-16 09:40AM  Teladoc Posts Narrower-than-Estimated Q4 Loss, Offers View
08:10AM  Charles River Laboratories International, Inc. breached its 50 day moving average in a Bullish Manner : CRL-US : March 3, 2016
Feb-29-16 05:00AM  Edited Transcript of CRL earnings conference call or presentation 7-Aug-14 1:00pm GMT
Feb-12-16 04:43PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 10-K, Annual Report
Feb-11-16 10:10AM  Charles River Laboratories International, Inc. Earnings Analysis: 2015 By the Numbers
Feb-10-16 10:32AM  Edited Transcript of CRL earnings conference call or presentation 10-Feb-16 1:30pm GMT +5.65%
Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery and development services worldwide. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains primarily genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening preclinical drug candidates comprising genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for identification of a druggable target through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, which comprise bioanalysis, pharmacokinetics, drug metabolism, toxicology, and pathology services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile biopharmaceuticals, and consumer products. This segment also offers specialized testing of biologics and devices that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free fertile chicken eggs and chickens used in the manufacture of live viruses. The company serves pharmaceutical and biotechnology companies, contract research organizations, agricultural and chemical companies, life science and veterinary medicine companies, contract manufacturing organizations, medical device companies, diagnostic and other commercial entities, hospitals, academic institutions, and government agencies. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MILNE GEORGE M JRDirectorFeb 14Option Exercise30.4410,710326,01239,240Feb 15 02:39 PM
MILNE GEORGE M JRDirectorFeb 14Sale86.5210,710926,62928,530Feb 15 02:39 PM
JOHST DAVID PCorporate Executive VPJan 30Option Exercise37.9213,950528,984174,696Feb 01 08:32 AM
JOHST DAVID PCorporate Executive VPJan 30Sale78.0013,9501,088,100160,746Feb 01 08:32 AM
WALLMAN RICHARD FDirectorDec 13Option Exercise33.934,540154,04220,990Dec 14 09:55 AM
CHUBB STEPHEN DDirectorDec 02Option Exercise30.4410,710326,01230,849Dec 05 02:59 PM
CHUBB STEPHEN DDirectorDec 02Sale71.574,564326,64526,285Dec 05 02:59 PM
REESE C RICHARDDirectorNov 28Option Exercise30.4410,710326,01244,943Nov 29 08:43 AM
REESE C RICHARDDirectorNov 28Sale71.934,539326,48540,404Nov 29 08:43 AM
Molho DavideCorporate Executive VPAug 30Sale84.107,877662,44630,493Sep 01 10:34 AM
FOSTER JAMES CChairman, President and CEOAug 05Sale86.913,830332,849323,636Aug 09 12:13 PM
FOSTER JAMES CChairman, President and CEOAug 05Sale86.308,703751,059327,466Aug 09 12:12 PM
FOSTER JAMES CChairman, President and CEOAug 05Sale85.9515,9411,370,104336,169Aug 09 12:10 PM
FOSTER JAMES CChairman, President and CEOAug 05Sale85.8013,1751,130,379352,110Aug 09 12:08 PM
FOSTER JAMES CChairman, President and CEOAug 05Sale85.6318,3511,571,433365,285Aug 09 12:06 PM
WALLMAN RICHARD FDirectorJul 29Option Exercise40.277,740311,69024,190Aug 01 04:00 PM
WALLMAN RICHARD FDirectorJul 29Sale88.007,740681,12016,450Aug 01 04:00 PM
MASSARO GEORGEDirectorJul 01Option Exercise33.934,540154,04218,935Jul 05 01:17 PM
MASSARO GEORGEDirectorJul 01Sale83.5480066,83114,395Jul 05 01:19 PM
MASSARO GEORGEDirectorJul 01Sale83.093,740310,75015,195Jul 05 01:17 PM
WALLMAN RICHARD FDirectorMay 13Sale82.321,970162,18016,450May 16 03:01 PM
MASSARO GEORGEDirectorMay 09Sale82.1798580,94212,135May 10 01:15 PM
Molho DavideCorporate Executive VPApr 06Option Exercise37.9630,6671,164,04490,012Apr 08 07:05 AM
Molho DavideCorporate Executive VPApr 06Sale80.0030,6672,453,36059,345Apr 08 07:05 AM
GILLETT NANCYCorporate Executive VPMar 02Option Exercise44.3115,419683,19033,726Mar 04 12:05 PM
FOSTER JAMES CChairman, President and CEOMar 02Option Exercise59.4120,0721,192,478403,708Mar 04 06:40 PM
GILLETT NANCYCorporate Executive VPMar 02Sale75.8282262,32811,034Mar 04 12:12 PM
GILLETT NANCYCorporate Executive VPMar 02Sale75.505,080383,55311,856Mar 04 12:09 PM
GILLETT NANCYCorporate Executive VPMar 02Sale75.219,775735,21316,936Mar 04 12:07 PM
GILLETT NANCYCorporate Executive VPMar 02Sale75.007,015526,12526,711Mar 04 12:05 PM
FOSTER JAMES CChairman, President and CEOMar 02Sale75.0020,0721,505,400383,636Mar 04 06:40 PM
GILLETT NANCYCorporate Executive VPFeb 29Sale73.503,646267,98118,307Feb 29 05:43 PM
JOHST DAVID PCorporate Executive VPFeb 25Option Exercise24.8034,075845,060189,023Feb 29 05:47 PM
JOHST DAVID PCorporate Executive VPFeb 25Sale73.0234,0752,488,146154,948Feb 29 05:47 PM
FOSTER JAMES CChairman, President and CEOFeb 24Option Exercise36.2524,388884,065402,707Feb 26 12:17 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale72.8980058,309378,319Feb 26 12:32 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale72.104,162300,073382,672Feb 26 12:29 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale72.543,553257,741379,119Feb 26 12:30 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale71.324,500320,919390,834Feb 26 12:25 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale71.774,000287,097386,834Feb 26 12:27 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale70.793,500247,768395,334Feb 26 12:20 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale70.403,873272,644398,834Feb 26 12:17 PM